Literature DB >> 10804143

Organization and expression of calicivirus genes.

I N Clarke1, P R Lambden.   

Abstract

The application of molecular techniques to the characterization of caliciviruses has resulted in an extensive database of sequence information. This information has led to the identification of 4 distinct genera. The human enteric caliciviruses have been assigned to 2 of these genera. This division is reflected not only in sequence diversity but in a fundamental difference in genome organization. Complete genome sequences are now available for 5 enteric caliciviruses and demonstrate that human and animal enteric caliciviruses are phylogenetically closely related. Currently, there is no cell culture system for the human viruses; therefore, studies have relied on heterologous expression and in vitro systems. These studies have shown that in both human and animal viruses the viral nonstructural proteins are produced from a polyprotein precursor that is cleaved by a single viral protease. The purpose of this article is to provide an overview of the current knowledge of genome structure and gene expression in the enteric caliciviruses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10804143     DOI: 10.1086/315575

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  63 in total

1.  Snow Mountain virus genome sequence and virus-like particle assembly.

Authors:  Vance P Lochridge; Michele E Hardy
Journal:  Virus Genes       Date:  2003-01       Impact factor: 2.332

2.  The murine norovirus core subgenomic RNA promoter consists of a stable stem-loop that can direct accurate initiation of RNA synthesis.

Authors:  Muhammad Amir Yunus; Xiaoyan Lin; Dalan Bailey; Ioannis Karakasiliotis; Yasmin Chaudhry; Surender Vashist; Guo Zhang; Lucy Thorne; C Cheng Kao; Ian Goodfellow
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

3.  The genome-linked protein VPg of the Norwalk virus binds eIF3, suggesting its role in translation initiation complex recruitment.

Authors:  Katie F Daughenbaugh; Chris S Fraser; John W B Hershey; Michele E Hardy
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

4.  Inactivation of caliciviruses.

Authors:  Erwin Duizer; Paul Bijkerk; Barry Rockx; Astrid De Groot; Fleur Twisk; Marion Koopmans
Journal:  Appl Environ Microbiol       Date:  2004-08       Impact factor: 4.792

5.  Novel recombinant norovirus causing outbreaks of gastroenteritis in Santiago, Chile.

Authors:  Roberto Vidal; Patricia Roessler; Verónica Solari; Jimena Vollaire; Xi Jiang; David O Matson; Nora Mamani; Valeria Prado; Miguel L O'Ryan
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

6.  Genetic variability in the sapovirus capsid protein.

Authors:  Mineyuki Okada; Yasutaka Yamashita; Mitsuaki Oseto; Tomoko Ogawa; Ikuo Kaiho; Kuniko Shinozaki
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

7.  The mechanism of an exceptional case of reinitiation after translation of a long ORF reveals why such events do not generally occur in mammalian mRNA translation.

Authors:  Tuija A A Pöyry; Ann Kaminski; Emma J Connell; Christopher S Fraser; Richard J Jackson
Journal:  Genes Dev       Date:  2007-12-01       Impact factor: 11.361

8.  Characterization of an enteropathogenic bovine calicivirus representing a potentially new calicivirus genus.

Authors:  J R Smiley; K O Chang; J Hayes; J Vinjé; L J Saif
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Chlorine inactivation of adenovirus type 40 and feline calicivirus.

Authors:  Jeanette A Thurston-Enriquez; Charles N Haas; Joseph Jacangelo; Charles P Gerba
Journal:  Appl Environ Microbiol       Date:  2003-07       Impact factor: 4.792

10.  Norwalk virus nonstructural protein p48 forms a complex with the SNARE regulator VAP-A and prevents cell surface expression of vesicular stomatitis virus G protein.

Authors:  Khalil Ettayebi; Michele E Hardy
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.